Last updated on March 2020

Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines

Brief description of study

This is a multicenter, randomized, double-blind and placebo-controlled phase 2b dose-finding study to assess the efficacy and safety of LOU064 in adults chronic spontaneous urticaria (CSU) patients inadequately controlled by H1-antihistamines

Clinical Study Identifier: NCT03926611

Find a site near you

Start Over

Novartis Investigative Site

Yokohama, Japan
  Connect »